Irene Fiore Merighi

1PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jun 27, 2022
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.

Antonino Di Lorenzo, Elisabetta Bolli, Roberto Ruiu

Pageof 1

Frequent Collaborators

1 joint publications

Antonino Di Lorenzo

1 joint publications

Elisabetta Bolli

1 joint publications

Roberto Ruiu

1 joint publications

Giuseppe Ferrauto

1 joint publications

Enza Di Gregorio

1 joint publications

Lidia Avalle

1 joint publications

Aurora Savino

1 joint publications

Federica Riccardo

1 joint publications

Mara Brancaccio

1 joint publications

Elena Quaglino

Frequent Collaborators

1 joint publications

Antonino Di Lorenzo

1 joint publications

Elisabetta Bolli

1 joint publications

Roberto Ruiu

1 joint publications

Giuseppe Ferrauto

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

2.8K
See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

2.8K
See more related videos